SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950135-03-001736
Filing Date
2003-03-13
Accepted
2003-03-13 09:06:49
Documents
1
Period of Report
2003-03-06

Document Format Files

Seq Description Document Type Size
1 MARK KESSEL - ANTIGENICS, INC. b45934f3e3.htm 3 23905
  Complete submission text file 0000950135-03-001736.txt   25694
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Subject) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-29089 | Film No.: 03601643
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 950 PARK AVE APT. 11A NEW YORK NY 10028
Business Address
KESSEL MARK (Reporting) CIK: 0001222013 (see all company filings)